Migraine and obesity: what is the real direction of their association?

References

• Bigal ME. The association between migraine and obesity: empty calories? London England: Sage Publications Sage UK; 2012. p. 950–952.
   Google Scholar
• Peterlin BL. The role of the adipocytokines adiponectin and leptin in migraine. J Osteopath Med. 2009;109(6):314–317.
   Google Scholar
• Ashina M, Katsarava Z, Do TP, et al. Migraine: epidemiology and systems of care. Lancet. 2021;397:1485–1495.
   PubMed Web of Science ®Google Scholar
• WHO obesity and overweight fact sheet: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight#:~:text=Worldwide%20obesity%20has%20nearly%20tripled.Cawo. Access date: Mar 2022
   Google Scholar
• Bond DS, Roth J, Nash JM, et al. Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment. Obesity Rev. 2011;12(5):e362–e71.
   PubMed Web of Science ®Google Scholar
• Verrotti A, Carotenuto M, Altieri L, et al. Migraine and obesity: metabolic parameters and response to a weight loss programme. Pediatr Obes. 2015;10(3):220–225.
   PubMed Web of Science ®Google Scholar
• Verrotti A, Agostinelli S, D’Egidio C, et al. Impact of a weight loss program on migraine in obese adolescents. Eur J Neurol. 2013;20(2):394–397.
   PubMed Web of Science ®Google Scholar
• Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology. 2006;67(2):252–257.
   PubMed Web of Science ®Google Scholar
• Gelaye B, Sacco S, Brown WJ, et al. Body composition status and the risk of migraine: a meta-analysis. Neurology. 2017;88(19):1795–1804.
   PubMed Web of Science ®Google Scholar
• Winter AC, Wang L, Buring JE, et al., Migraine, weight gain and the risk of becoming overweight and obese: a prospective cohort study. Cephalalgia. 2012. 32(13):963–971.
   PubMed Web of Science ®Google Scholar
• Silberstein S. Migraine pathophysiology and its clinical implications. Cephalalgia. 2004;24(2_suppl):2–7.
   PubMedGoogle Scholar
• Villalón CM, Olesen J. The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs. Pharmacol Ther. 2009;124(3):309–323.
   PubMed Web of Science ®Google Scholar
• Charles A. The pathophysiology of migraine: implications for clinical management. Lancet Neurol. 2018;17(2):174–182.
   PubMed Web of Science ®Google Scholar
• Panconesi A. Serotonin and migraine: a reconsideration of the central theory. J Headache Pain. 2008;9(5):267–276.
   PubMed Web of Science ®Google Scholar
• Sicuteri F, Testi A, Anselmi B. Biochemical investigations in headache: increase in the hydroxyindoleacetic acid excretion during migraine attacks. Int Arch Allergy Immunol. 1961;19(1):55–58.
   Web of Science ®Google Scholar
• Ferrari MD, Saxena PR. On serotonin and migraine: a clinical and pharmacological review. Cephalalgia. 1993;13(3):151–165.
   PubMed Web of Science ®Google Scholar
• Ferrari M, Odink J, Tapparelli C, et al. Serotonin metabolism in migraine. Neurology. 1989;39(9):1239.
   PubMed Web of Science ®Google Scholar
• Humphrey P. 5-hydroxytryptamine and the pathophysiology of migraine. J Neurol. 1991;238(1):S38–S44.
   PubMedGoogle Scholar
• Fanciullacci M, Alessandri M, Del Rosso A. Dopamine involvement in the migraine attack. Funct Neurol. 2000;15(Suppl 3):171–181.
   PubMed Web of Science ®Google Scholar
• Chai NC, Bond DS, Moghekar A, et al., Obesity and headache: part II–potential mechanism and treatment considerations. Headache. 2014. 54(3):459–471.
   PubMed Web of Science ®Google Scholar
• Edvinsson L, Haanes KA, Warfvinge K. Does inflammation have a role in migraine? Nat Rev Neurol. 2019;15(8):483–490.
   PubMed Web of Science ®Google Scholar
• Perini F, D’Andrea G, Galloni E, et al. Plasma cytokine levels in migraineurs and controls. Headache. 2005;45(7):926–931.
   PubMed Web of Science ®Google Scholar
• Sarchielli P, Alberti A, Baldi A, et al. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache. 2006;46(2):200–207.
   PubMed Web of Science ®Google Scholar
• Yücel M, Kotan D, Gurol Çiftçi G, et al. Serum levels of endocan, claudin-5 and cytokines in migraine. Eur Rev Med Pharmacol Sci. 2016;20(5):930–936.
   PubMed Web of Science ®Google Scholar
• Vozarova B, Weyer C, Lindsay RS, et al. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002;51(2):455–461.
   PubMed Web of Science ®Google Scholar
• Rehman K, Akash MSH. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? J Biomed Sci. 2016;23(1):87.
   PubMed Web of Science ®Google Scholar
• Qatanani M, Tan Y, Dobrin R, et al. Inverse regulation of inflammation and mitochondrial function in adipose tissue defines extreme insulin sensitivity in morbidly obese patients. Diabetes. 2013;62(3):855–863.
   PubMed Web of Science ®Google Scholar
• Hauner H. Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc. 2005;64(2):163–169.
   PubMed Web of Science ®Google Scholar
• Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc. 2001;60(3):349–356.
   PubMed Web of Science ®Google Scholar
• Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6. Diabetes Res Clin Pract. 2005;69(1):29–35.
   PubMed Web of Science ®Google Scholar
• Recober A, Goadsby PJ. Calcitonin gene-related peptide (CGRP): a molecular link between obesity and migraine? Drug News Perspect. 2010;23(2):112.
   PubMedGoogle Scholar
• Ramón C, Cernuda-Morollón E, Pascual J. Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine. Curr Opin Neurol. 2017;30(3):281–286.
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993;33(1):48–56.
   PubMed Web of Science ®Google Scholar
• Juhász G, Zsombok T, Jakab B, et al. Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Cephalalgia. 2005;25(3):179–183.
   PubMed Web of Science ®Google Scholar
• Edvinsson L. The journey to establish CGRP as a migraine target: a retrospective view. Headache. 2015;55(9):1249–1255.
   PubMed Web of Science ®Google Scholar
• Dx G, AJ H, Wilken M, et al. Plasma calcitonin gene-related peptide is increased prior to obesity, and sensory nerve desensitization by capsaicin improves oral glucose tolerance in obese Zucker rats. Eur J Endocrinol. 2005;153(6):963–969.
   PubMed Web of Science ®Google Scholar
• Zelissen PM, Koppeschaar HP, Lips CJ, et al. Calcitonin gene-related peptide in human obesity. Peptides. 1991;12(4):861–863.
   PubMed Web of Science ®Google Scholar
• Joyce C, Fiscus R, Wang X, et al. Calcitonin gene-related peptide levels are elevated in patients with sepsis. Surgery. 1990;108(6):1097–1101.
   PubMed Web of Science ®Google Scholar
• Reich A, Orda A, Wiśnicka B, et al. Plasma concentration of selected neuropeptides in patients suffering from psoriasis. Exp Dermatol. 2007;16(5):421–428.
   PubMed Web of Science ®Google Scholar
• Cardell L, Uddman R, Edvinsson L. Low plasma concentrations of VIP and elevated levels of other neuropeptides during exacerbations of asthma. Eur Respir J. 1994;7(12):2169–2173.
   PubMed Web of Science ®Google Scholar
• Olesen J, Thomsen LL, Iversen H. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci. 1994;15(5):149–153.
   PubMed Web of Science ®Google Scholar
• Olesen J. The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther. 2008;120(2):157–171.
   PubMed Web of Science ®Google Scholar
• Kruuse C, Thomsen LL, Birk S, et al. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain. 2003;126(1):241–247.
   PubMedGoogle Scholar
• Kruuse C, Thomsen LL, Jacobsen TB, et al. The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects. J Cereb Blood Flow Metab. 2002;22(9):1124–1131.
   PubMed Web of Science ®Google Scholar
• Pradhan AA, Bertels Z, Akerman S. Targeted nitric oxide synthase inhibitors for migraine. Neurotherapeutics. 2018;15(2):391–401.
   PubMed Web of Science ®Google Scholar
• Szabo C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett. 2003;140:105–112.
   PubMed Web of Science ®Google Scholar
• Moncada S. Nitric oxide. J Hypertens Suppl. 1994;12(10):S35–9.
   PubMedGoogle Scholar
• Goadsby PJ. The vascular theory of migraine—a great story wrecked by the facts. Brain. 2009;132(1):6–7.
   PubMed Web of Science ®Google Scholar
• Mason BN, Russo AF. Vascular contributions to migraine: time to revisit? Front Cell Neurosci. 2018;12:233.
   PubMed Web of Science ®Google Scholar
• Gaskin FS, Farr SA, Banks WA, et al. Ghrelin-induced feeding is dependent on nitric oxide. Peptides. 2003;24(6):913–918.
   PubMed Web of Science ®Google Scholar
• Székely M, Soós S, Pétervári E, et al. Nutritional impact on anabolic and catabolic signaling. Elsevier: Molecular Basis of Nutrition and Aging; 2016. p. 189–204.
   Google Scholar
• Sobrino Crespo C, Perianes Cachero A, Puebla Jimenez L, et al. Peptides and food intake. Front Endocrinol (Lausanne). 2014;5:58.
   PubMed Web of Science ®Google Scholar
• Morley JE, Farr SA, Sell RL, et al. Nitric oxide is a central component in neuropeptide regulation of appetite. Peptides. 2011;32(4):776–780.
   PubMed Web of Science ®Google Scholar
• Hamel E, Saxena PR. 2006. 5-hydroxytryptamine involvement in migraine. The headaches. 2:319–324.
   Google Scholar
• Peterlin BL, Rapoport AM. Clinical pharmacology of the serotonin receptor agonist, zolmitriptan. Expert Opin Drug Metab Toxicol. 2007;3(6):899–911.
   PubMed Web of Science ®Google Scholar
• Fanibunda SE, Deb S, Maniyadath B, et al. Serotonin regulates mitochondrial biogenesis and function in rodent cortical neurons via the 5-HT2A receptor and SIRT1–PGC-1α axis. Proc Nat Acad Sci. 2019;116(22):11028–11037.
   PubMed Web of Science ®Google Scholar
• Nonogaki K, Strack AM, Dallman MF, et al. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat Med. 1998;4(10):1152–1156.
   PubMed Web of Science ®Google Scholar
• Chieffi S, Carotenuto M, Monda V, et al. Orexin system: the key for a healthy life. Front Physiol. 2017;8:357.
   PubMed Web of Science ®Google Scholar
• Kuru M, Ueta Y, Serino R, et al. Centrally administered orexin/hypocretin activates HPA axis in rats. Neuroreport. 2000;11(9):1977–1980.
   PubMed Web of Science ®Google Scholar
• Razavi BM, Hosseinzadeh H. A review of the role of orexin system in pain modulation. Biomed Pharmacother. 2017;90:187–193.
   PubMed Web of Science ®Google Scholar
• Chiou L-C, Lee H-J, Ho Y-C, et al. Orexins/hypocretins: pain regulation and cellular actions. Curr Pharm Des. 2010;16(28):3089–3100.
   PubMed Web of Science ®Google Scholar
• Mobarakeh JI, Takahashi K, Sakurada S, et al. Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice. Pain. 2005;118(1–2):254–262.
   PubMed Web of Science ®Google Scholar
• PR H, Akerman S, PJ G. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception. J Pharmacol Exp Ther. 2005;315(3):1380–1385.
   PubMed Web of Science ®Google Scholar
• Sarchielli P, Rainero I, Coppola F, et al. Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid. Cephalalgia. 2008;28(7):714–722.
   PubMed Web of Science ®Google Scholar
• Tsujino N, Sakurai T. Role of orexin in modulating arousal, feeding, and motivation. Front Behav Neurosci. 2013;7:28.
   PubMed Web of Science ®Google Scholar
• Teske JA, Mavanji V. Energy expenditure: role of orexin. Vitamins Hormones. 2012;89:91–109.
   PubMed Web of Science ®Google Scholar
• Milbank E, López M. Orexins/hypocretins: key regulators of energy homeostasis. Front Endocrinol (Lausanne). 2019;10:830.
   PubMed Web of Science ®Google Scholar
• Li M, Meng Y, Chu B, et al. Orexin-A aggravates cytotoxicity and mitochondrial impairment in SH-SY5Y cells transfected with APPswe via p38 MAPK pathway. Ann Transl Med. 2020;8:1.
   PubMed Web of Science ®Google Scholar
• de Mello AH, Costa AB, Engel JDG, et al. Mitochondrial dysfunction in obesity. Life Sci. 2018;192:26–32.
   PubMed Web of Science ®Google Scholar
• Peterlin BL, Alexander G, Tabby D, et al., Oligomerization state-dependent elevations of adiponectin in chronic daily headache. Neurology. 2008. 70(20):1905–1911.
   PubMed Web of Science ®Google Scholar
• Peterlin BL, Tietjen GE, Gower BA, et al. Ictal adiponectin levels in episodic migraineurs: a randomized pilot trial. Headache. 2013;53(3):474–490.
   PubMed Web of Science ®Google Scholar
• Hellström L, Wahrenberg H, Hruska K, et al. Mechanisms behind gender differences in circulating leptin levels. J Intern Med. 2000;247(4):457–462.
   PubMed Web of Science ®Google Scholar
• Rosenbaum M, Leibel RL. 20 years of leptin: role of leptin in energy homeostasis in humans. J Endocrinol. 2014;223(1):T83–T96.
   PubMed Web of Science ®Google Scholar
• Leibel RL. The role of leptin in the control of body weight. Nutr Rev. 2002;60(suppl_10):S15–S9.
   PubMed Web of Science ®Google Scholar
• Tian Y, Wang S, Ma Y, et al. Leptin enhances NMDA-induced spinal excitation in rats: a functional link between adipocytokine and neuropathic pain. Pain. 2011;152(6):1263–1271.
   PubMed Web of Science ®Google Scholar
• Iikuni N, Kwan Lam QL, Lu L, et al. Leptin and inflammation. Curr Immunol Rev. 2008;4(2):70–79.
   PubMedGoogle Scholar
• Berilgen M, Bulut S, Gonen M, et al. Comparison of the effects of amitriptyline and flunarizine on weight gain and serum leptin, C peptide and insulin levels when used as migraine preventive treatment. Cephalalgia. 2005;25(11):1048–1053.
   PubMed Web of Science ®Google Scholar
• Guldiken B, Guldiken S, Demir M, et al. Low leptin levels in migraine: a case control study. Headache. 2008;48(7):1103–1107.
   PubMed Web of Science ®Google Scholar
• Bernecker C, Pailer S, Kieslinger P, et al. Increased matrix metalloproteinase activity is associated with migraine and migraine‐related metabolic dysfunctions. Eur J Neurol. 2011;18(4):571–576.
   PubMed Web of Science ®Google Scholar
• Bernecker C, Ragginer C, Fauler G, et al. Oxidative stress is associated with migraine and migraine‐related metabolic risk in females. Eur J Neurol. 2011;18(10):1233–1239.
   PubMed Web of Science ®Google Scholar
• Enriori PJ, Evans AE, Sinnayah P, et al. Leptin resistance and obesity. Obesity. 2006;14(S8):254S–8S.
   PubMedGoogle Scholar
• Missale C, Nash SR, Robinson SW, et al. Dopamine receptors: from structure to function. Physiol Rev. 1998;78(1):189–225.
   PubMed Web of Science ®Google Scholar
• Wang G-J, Volkow ND, Thanos PK, et al. Imaging of brain dopamine pathways: implications for understanding obesity. J Addict Med. 2009;3(1):8.
   PubMed Web of Science ®Google Scholar
• Wang G-J, Volkow ND, Fowler JS. The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin Ther Targets. 2002;6(5):601–609.
   PubMedGoogle Scholar
• Fulton S. Appetite and reward. Front Neuroendocrinol. 2010;31(1):85–103.
   PubMed Web of Science ®Google Scholar
• Charbit AR, Akerman S, Goadsby PJ. Dopamine: what’s new in migraine? Curr Opin Neurol. 2010;23(3):275–281.
   PubMed Web of Science ®Google Scholar
• Cerbo R, Barbanti P, Buzzi M, et al. Dopamine hypersensitivity in migraine: role of the apomorphine test. Clin Neuropharmacol. 1997;20(1):36–41.
   PubMed Web of Science ®Google Scholar
• Marmura MJ. Use of dopamine antagonists in treatment of migraine. Curr Treat Options Neurol. 2012;14(1):27–35.
   PubMed Web of Science ®Google Scholar
• Martami F, Ghorbani Z, Abolhasani M, et al. Comorbidity of gastrointestinal disorders, migraine, and tension-type headache: a cross-sectional study in Iran. Neurol Sci. 2018;39(1):63–70.
   PubMed Web of Science ®Google Scholar
• Cámara-Lemarroy CR, Rodriguez-Gutierrez R, Monreal-Robles R, et al. Gastrointestinal disorders associated with migraine: a comprehensive review. World J Gastroenterol. 2016;22(36):8149.
   PubMed Web of Science ®Google Scholar
• Fu P, Gao M, Yung KKL. Association of intestinal disorders with Parkinson’s disease and Alzheimer’s disease: a systematic review and meta-analysis. ACS Chem Neurosci. 2019;11(3):395–405.
   Web of Science ®Google Scholar
• Marrie RA, Reider N, Stuve O, et al. The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: a systematic review. Mult Scler J. 2015;21(3):332–341.
   PubMed Web of Science ®Google Scholar
• Maguire M, Maguire G. Gut dysbiosis, leaky gut, and intestinal epithelial proliferation in neurological disorders: towards the development of a new therapeutic using amino acids, prebiotics, probiotics, and postbiotics. Rev Neurosci. 2019;30(2):179–201.
   PubMed Web of Science ®Google Scholar
• Tang Y, Liu S, Shu H, et al. Gut microbiota dysbiosis enhances migraine-like pain via TNFα upregulation. Mol Neurobiol. 2020;57(1):461–468.
   PubMed Web of Science ®Google Scholar
• Bienenstock J, Kunze W, Forsythe P. Microbiota and the gut–brain axis. Nutr Rev. 2015;73(suppl_1):28–31.
   PubMedGoogle Scholar
• Chen J, Wang Q, Wang A, et al. Structural and functional characterization of the gut microbiota in elderly women with migraine. Front Cell Infect Microbiol. 2020;9:470.
   PubMed Web of Science ®Google Scholar
• Hindiyeh N, Aurora SK. What the gut can teach us about migraine. Curr Pain Headache Rep. 2015;19(7):1–8.
   Web of Science ®Google Scholar
• Arzani M, Jahromi SR, Ghorbani Z, et al. Gut-brain Axis and migraine headache: a comprehensive review. J Headache Pain. 2020;21(1):1–12.
   PubMed Web of Science ®Google Scholar
• Amabebe E, Robert FO, Agbalalah T, et al. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism. Br J Nutr. 2020;123(10):1127–1137.
   PubMed Web of Science ®Google Scholar
• Angelakis E, Armougom F, Million M, et al. The relationship between gut microbiota and weight gain in humans. Future Microbiol. 2012;7(1):91–109.
   PubMed Web of Science ®Google Scholar
• Santacruz A, Collado MC, Garcia-Valdes L, et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr. 2010;104(1):83–92.
   PubMed Web of Science ®Google Scholar
• Saad M, Santos A, Prada P. Linking gut microbiota and inflammation to obesity and insulin resistance. Physiology. 2016;31:283–293.
   PubMed Web of Science ®Google Scholar
• Bigal ME, Lipton RB. The epidemiology, burden, and comorbidities of migraine. Neurol Clin. 2009;27(2):321–334.
   PubMed Web of Science ®Google Scholar
• Lantéri-Minet M, Radat F, Chautard M-H, et al. Anxiety and depression associated with migraine: influence on migraine subjects’ disability and quality of life, and acute migraine management. Pain. 2005;118(3):319–326.
   PubMed Web of Science ®Google Scholar
• Antonaci F, Nappi G, Galli F, et al. Migraine and psychiatric comorbidity: a review of clinical findings. J Headache Pain. 2011;12(2):115–125.
   PubMed Web of Science ®Google Scholar
• Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res. 1991;37(1):11–23.
   PubMed Web of Science ®Google Scholar
• Merikangas KR, Angst J, Isler H. Migraine and psychopathology: results of the zurich cohort study of young adults. Arch Gen Psychiatry. 1990;47(9):849–853.
   PubMed Web of Science ®Google Scholar
• Hamelsky SW, Lipton RB. Psychiatric comorbidity of migraine. Headache. 2006;46(9):1327–1333.
   PubMed Web of Science ®Google Scholar
• Amiri S, Behnezhad S, Azad E. Migraine headache and depression in adults: a systematic review and meta-analysis. neuropsychiatrie. 2019;33(3):131–140.
   PubMed Web of Science ®Google Scholar
• Lasserre AM, Glaus J, Vandeleur CL, et al. Depression with atypical features and increase in obesity, body mass index, waist circumference, and fat mass: a prospective, population-based study. JAMA psychiatry. 2014;71(8):880–888.
   PubMed Web of Science ®Google Scholar
• Brumpton B, Langhammer A, Romundstad P, et al. The associations of anxiety and depression symptoms with weight change and incident obesity: the HUNT study. Int J Obesity. 2013;37(9):1268–1274.
   Web of Science ®Google Scholar
• Faith M, Butryn M, Wadden T, et al. Evidence for prospective associations among depression and obesity in population‐based studies. Obesity Rev. 2011;12(5):e438–e53.
   PubMedGoogle Scholar
• Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67(3):220–229.
   PubMed Web of Science ®Google Scholar
• Farris SG, Thomas JG, Abrantes AM, et al. Intentional avoidance of physical activity in women with migraine. Cephalalgia Rep. 2018;1:2515816318788284.
   Google Scholar
• Gazerani P. A bidirectional view of migraine and diet relationship. Neuropsychiatr Dis Treat. 2021;17:435.
   PubMed Web of Science ®Google Scholar
• Krøll LS, Hammarlund CS, Westergaard ML, et al. Level of physical activity, well-being, stress and self-rated health in persons with migraine and co-existing tension-type headache and neck pain. J Headache Pain. 2017;18(1):1–9.
   PubMedGoogle Scholar
• Varkey E, Hagen K, Zwart J, et al. Physical activity and headache: results from the nord-trøndelag health study (HUNT). Cephalalgia. 2008;28(12):1292–1297.
   PubMed Web of Science ®Google Scholar
• Pietiläinen KH, Kaprio J, Borg P, et al. Physical inactivity and obesity: a vicious circle. Obesity. 2008;16(2):409–414.
   PubMed Web of Science ®Google Scholar
• Buse D, Manack A, Serrano D, et al. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg. 2010;81(4):428–432.
   PubMed Web of Science ®Google Scholar
• Katsarava Z, Buse DC, Manack AN, et al. Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2012;16(1):86–92.
   PubMed Web of Science ®Google Scholar
• Bretón‐Romero R, Weisbrod RM, Feng B, et al. Liraglutide treatment reduces endothelial endoplasmic reticulum stress and insulin resistance in patients with diabetes mellitus. J Am Heart Assoc. 2018;7(18):e009379.
   PubMed Web of Science ®Google Scholar
• Ladenheim EE. Liraglutide and obesity: a review of the data so far. Drug Des Devel Ther. 2015;9:1867.
   PubMed Web of Science ®Google Scholar
• Verna EC, Lucak S. Use of probiotics in gastrointestinal disorders: what to recommend? Therap Adv Gastroenterol. 2010;3(5):307–319.
   PubMedGoogle Scholar
• Martami F, Togha M, Seifishahpar M, et al. The effects of a multispecies probiotic supplement on inflammatory markers and episodic and chronic migraine characteristics: a randomized double-blind controlled trial. Cephalalgia. 2019;39(7):841–853.
   PubMed Web of Science ®Google Scholar
• Vo M, Ainalem A, Qiu C, et al. Body mass index and adult weight gain among reproductive age women with migraine. Headache. 2011;51(4):559–569.
   PubMed Web of Science ®Google Scholar
• Wessman M, Terwindt GM, Kaunisto MA, et al. Migraine: a complex genetic disorder. Lancet Neurol. 2007;6(6):521–532.
   PubMed Web of Science ®Google Scholar
• Honkasalo ML, Kaprio J, Winter T, et al. Migraine and concomitant symptoms among 8167 adult twin pairs. Headache. 1995;35(2):70–78.
   PubMed Web of Science ®Google Scholar
• Mulder EJ, Van Baal C, Gaist D, et al. Genetic and environmental influences on migraine: a twin study across six countries. Twin Res Human Genet. 2003;6(5):422–431.
   Google Scholar
• Hunter RL, Dragicevic N, Seifert K, et al. Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system. J Neurochem. 2007;100(5):1375–1386.
   PubMed Web of Science ®Google Scholar
• Ben‐Shachar D. Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J Neurochem. 2002;83(6):1241–1251.
   PubMed Web of Science ®Google Scholar
• Kusminski CM, Scherer PE. Mitochondrial dysfunction in white adipose tissue. Trends Endocrinol Metab. 2012;23(9):435–443.
   PubMed Web of Science ®Google Scholar
• Heinonen S, Buzkova J, Muniandy M, et al. Impaired mitochondrial biogenesis in adipose tissue in acquired obesity. Diabetes. 2015;64(9):3135–3145.
   PubMed Web of Science ®Google Scholar
• Yin X, Lanza IR, Swain JM, et al. Adipocyte mitochondrial function is reduced in human obesity independent of fat cell size. J Clin Endocrinol Metab. 2014;99(2):E209–E16.
   PubMed Web of Science ®Google Scholar
• Taylor FR. Weight change associated with the use of migraine-preventive medications. Clin Ther. 2008;30(6):1069–1080.
   PubMed Web of Science ®Google Scholar
• Young WB, Rozen T. Preventive treatment of migraine: effect on weight. Cephalalgia. 2005;25(1):1–11.
   PubMed Web of Science ®Google Scholar
• Maggioni F, Ruffatti S, Dainese F, et al. Weight variations in the prophylactic therapy of primary headaches: 6–month follow–up. J Headache Pain. 2005;6(4):322–324.
   PubMedGoogle Scholar